Sterilization News and Research

RSS

Bluechiip, STMicroelectronics enter partnership to manufacture unique MEMS-based tracking tags

STMicroelectronics, the leading supplier of MEMS devices for consumer and portable applications, and Bluechiip Limited, an innovative early-stage company that has developed a groundbreaking tracking solution, today announced that the two companies are to cooperate in the manufacturing of unique MEMS-based tracking tags, aimed at a range of different markets, but initially in healthcare, such as biobanks.

20 Jan 2011

Alimera receives FDA CRL for ILUVIEN NDA

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN® for the treatment of Diabetic Macular Edema (DME), today announced that Alimera Sciences, Inc, pSivida's collaborative partner, received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ILUVIEN. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form.

24 Dec 2010

Mesa Labs announces acquisition of Apex's biological indicators business

Mesa Laboratories, Inc., a Lakewood, Colorado based manufacturer of electronic instruments and disposables today announced the acquisition of the biological indicators business of Apex Laboratories, Inc., a North Carolina based company. The acquisition of the Apex business is expected to be immediately accretive to Mesa's earnings per share.

22 Dec 2010

Group buy program helps hospitals save $81 million

Over the past year, 1,220 hospitals participating in the Premier healthcare alliance's group buy program have identified $81 million in savings through access to high-quality products at low costs.

21 Dec 2010

Experts convene to discuss ethical, policy consideration of guidelines for disabled children

Should parents be able to use medical means to restrict the growth of profoundly disabled children to make them easier to care for at home. A working group convened to discuss the ethical and policy considerations of "growth attenuation" proposes some guidelines in an article in the Hastings Center Report. Personal essays including those of parents whose children cannot walk or speak accompany the article

1 Dec 2010

Glenn Foundation awards $60,000 grant to Scripps' scientist for biomedical research

While scientists depend on grants for their research, applying for them is a long and frequently frustrating process. For one Scripps Research Institute scientist, however, the process was shorter.

19 Nov 2010

Oregon scientist investigates safety, effectiveness of novel low-cost family-planning option

The Bill & Melinda Gates Foundation has awarded nationally prominent Oregon Health & Science University reproductive scientist Jeffrey T. Jensen, M.D., M.P.H., a $100,000 grant to investigate the safety and effectiveness of a novel low-cost family-planning option that may be applicable to women in low-resource countries worldwide.

15 Nov 2010

Electrolytic Ozone completes Series A funding

Electrolytic Ozone Inc. (EOI) today announced completion of Series A funding. EOI develops and manufactures ultra-compact, safe and reliable ozone generators that harness the benefits of ozone to improve the safety and quality of the human environment. EOI ozone cells enable innovative sanitization, deodorization and preservation applications of ozone for consumer, food safety, health and medical uses.

4 Nov 2010

TSO3 third quarter revenue decreases from $126,162 to $122,759

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, posted revenues of $122,759 for the third quarter of 2010, ended September 30, for the sale of accessories and service contracts.

3 Nov 2010

Synergetics announces record sales leads generated from ophthalmic products

Synergetics USA, Inc. a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced record sales leads generated from the presentation of recently released ophthalmic products at the 2010 Annual Meeting of the American Academy of Ophthalmology (AAO). The AAO meeting was held in Chicago's McCormick Place on October 16-19, 2010.

26 Oct 2010

New sensor uses frog peptides to detect contamination in drugs, medical devices

Princeton engineers have developed a sensor that may revolutionize how drugs and medical devices are tested for contamination, and in the process also help ensure the survival of two species of threatened animals.

20 Oct 2010

U-M hopes to make concept of recycling pacemakers a life-saving reality

Millions worldwide die each year because they can't afford a pacemaker. Meanwhile heart patients in the United States say they'd be willing to donate theirs after death to someone in need.

20 Oct 2010

Johnson & Johnson third quarter sales decrease 0.7% to $15.0 billion

Johnson & Johnson today announced sales of $15.0 billion for the third quarter of 2010, a decrease of 0.7% as compared to the third quarter of 2009. Operational results increased 0.1% and the negative impact of currency was 0.8%. Domestic sales declined 2.5%, while international sales increased 1.1%, reflecting operational growth of 2.6% and a negative currency impact of 1.5%.

19 Oct 2010

NinePoint announces completion of $33 million Series A financing

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.

14 Oct 2010

NovaSterilis Inc. and Cornell researcher Dr. CC Chu awarded a Metropolitan Development Association grant

NovaSterilis, Lansing NY, and Dr. CC Chu were awarded a grant from the Metropolitan Development Association (MDA) to explore the feasibility of utilizing NovaSterilis supercritical co2 sterilization for a variety of absorbable biomaterials from both commercial and experimental sources.

11 Oct 2010

Hospital staff go on 4 hour strike over pay issues

Hospital staff across Western Australia will strike today for better pay. The Industrial Relations Commission failed to assure the government that it would stop workers from carrying out industrial action. On Friday, the union rejected an offer to increase their weekly pay by $27.

11 Oct 2010

Pharmaxis receives FDA approval to market ARIDOL Test Kit

Pharmaxis, a global specialty pharmaceutical company focused on therapeutic products for chronic respiratory and immune disorders, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market ARIDOL™ (mannitol inhalation powder) Bronchial Challenge Test Kit, the first new bronchial challenge test in more than two decades.

7 Oct 2010

Lawmaker proposes trust fund for veterans' growing health costs

"A new study estimates that health costs for Iraq and Afghanistan veterans could top $900 billion, and [Rep. Bob Filner, D-Calif.] wants to set up a trust fund to make sure the bill will be paid," The Associated Press reports.

1 Oct 2010

Health overhaul details trigger uncertainty, debate

The Orlando Sentinel: "It's one of the most overlooked pieces of health-care overhaul, but a plan to help companies pay health-care costs for early retirees has proved popular in Florida, where 69 companies and government agencies have applied for federal help.

22 Sep 2010

HHS urged not to cover contraception or sterilization in health plans

The Department of Health and Human Services (HHS) should not require coverage of contraception or sterilization in group and individual health plans as part of "preventive" services for women, said representatives of the United States Conference of Catholic Bishops (USCCB) as HHS continued its deliberations on a final list of required preventive services under the Patient Protection and Affordable Care Act (PPACA).

21 Sep 2010